StonvexLoading…
StonvexStonvexStonvexCore line items from SUNE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $7.19M | $71.91M | $44.69M | $25.70M |
Operating Income | $-4.33M | $-1.67M | $-4.58M | $-4.33M |
Net Income | $-4.09M | $-10.89M | $-13.50M | $-13.10M |
EPS (Diluted) | $-1.20 | $-4.38 | $-6.19 | $-8.42 |
Total Assets | $40.12M | $48.24M | $49.61M | $44.13M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.69M | $7.18M | $5.41M | $3.19M |
Free Cash Flow OCF − CapEx | Not available | $906.38K | $-1.16M | $-3.54M |
Shares Outstanding | 3.41M | 3.41M | 3.41M | 3.41M |